ArticleFrontiers in endocrinology2025

hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients.

Fengjiao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.